Moleculin Biotech (MBRX) Q4 2023 Earnings

22MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-5.09
-3.46
-1.82
-0.19

Details

Expected EPS
N/A
Actual EPS
-5.09
Surprise EPS
-5.09
Surprise Percent
+∞%

Description

Moleculin Biotech (MBRX) has reported earnings of -5.09 per share for Q4 2023.

0 Comments

Share your thoughts